Trying to figure out whether insurance covers GLP-1 medications in Washington? Here’s what to know about Ozempic, Wegovy, Mounjaro, Zepbound, Medicare, prior authorizations, and why the answer is so often: “Well… it depends.”
If you have tried to figure out whether your insurance will pay for a GLP-1 medication, you may have discovered an important fact:
Insurance is very good at making simple questions complicated.
You ask:
“Is Wegovy covered?”
And somehow the answer involves a formulary, a prior authorization, three phone calls, a fax machine, your diagnosis, your employer, and possibly the phase of the moon…
We can’t make insurance make sense. But we can help you understand what they’re talking about.
First: What Is a GLP-1 Medication?
GLP-1 medications are medicines that affect hormones involved in things like hunger, fullness, blood sugar, and digestion.
Some are approved to treat type 2 diabetes (Ozempic, Mounjaro, Victoza).
Some are approved to treat obesity or overweight with certain health conditions (Wegovy, Zepbound, Saxenda).
And then finally, all of these medications have an active ingredient which is different than their brand name (semaglutide, tirzepatide, liraglutide).
- Ozempic® = semaglutide
- Wegovy® = semaglutide
- Mounjaro® = tirzepatide
- Zepbound® = tirzepatide
- Victoza® = liraglutide
- Saxenda® = liraglutide
Same family reunion.
Different name tags.
And those name tags matter to insurance companies.
Does Insurance Cover GLP-1 Medications in Washington?
Sometimes.
We know. Very helpful…
Coverage depends on your specific insurance plan, not just the insurance company listed on your card.
Two people can both have the same insurance company and have completely different coverage—especially if they work for different employers.
Why?
Because employers and insurance plans can—and often do—choose different benefits.
One plan may cover medications for obesity.
Another may specifically exclude them. Unfortunately, we see this a lot.
Another may cover them, but only after certain requirements are met.
This is why your friend saying, “My insurance covered it!” does not necessarily mean yours will.
Same insurance company. Different plan. Different rules.
Life is unfair.
What Is a Prior Authorization?
A prior authorization is basically your insurance company saying:
“Before we pay for this, prove to us that you need it.”
Your medical provider may need to send information such as:
- Your diagnosis
- Your weight or BMI
- Health conditions related to your weight
- Medications you have already tried
- Previous weight-loss attempts
- Medical records showing why the medication is appropriate
The exact requirements depend on the insurance plan.
And meeting the medical requirements does not always guarantee coverage.
If your plan excludes obesity coverage, a beautifully completed prior authorization will still be denied.
You can’t prior-authorize your way around a benefit your plan doesn’t have.
Why Would Insurance Cover Ozempic but Not Wegovy?
This is one of the most confusing parts.
Ozempic and Wegovy both contain semaglutide.
But insurance coverage is based partly on what the medication is FDA approved to treat and therefore, why it is being prescribed.
Ozempic is associated primarily with treatment of type 2 diabetes.
Wegovy is approved for chronic weight management and has additional approved uses in certain patients.
That means a plan might cover Ozempic for someone with type 2 diabetes but refuse to cover it when prescribed only for weight loss.
Similarly, Mounjaro and Zepbound both contain tirzepatide, but they have different FDA-approved indications.
This is why asking:
“Does my insurance cover GLP-1s?”
is often not specific enough.
The better question is:
“Does my plan cover this medication for my diagnosis?”
Does Medicare Cover GLP-1 Medications?
Medicare coverage deserves its own special section because the rules around GLP-1 medications have been changing.
Historically, Medicare has excluded medications when they are used only for weight loss. However, some GLP-1 medications may be covered when they are prescribed for another FDA-approved medical condition and the patient meets the required criteria.
As of July 1, 2026, there is another option for some Medicare patients.
The Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge, a new program designed to give eligible people with Medicare Part D access to certain GLP-1 medications for weight management when they would not otherwise have access through their Part D benefit.
For patients who qualify, medications available through the program have a $50 monthly copay. The program currently runs through December 31, 2027.
There are specific eligibility requirements, and not every Medicare patient will qualify. A medical provider must also submit a prior authorization.
In other words:
If Medicare previously told you your GLP-1 was not covered, it may be worth asking again.
The rules changed on July 1, 2026.
We have created a separate guide explaining the Medicare GLP-1 Bridge, who may qualify, and what to do next.
→ Learn More About the Medicare GLP-1 Bridge
And because Medicare rules apparently enjoy changing just when we finally understand them, always check current eligibility requirements rather than relying on something you read online six months ago.
Yes, even if the person explaining it on TikTok seemed extremely confident.
How Can I Find Out if My Insurance Covers a GLP-1?
Start with your insurance card.
Call the member services or pharmacy benefits number and ask about your specific plan.
You can ask:
- “Is [medication name] on my formulary?”
- “What diagnoses or medical conditions is this medication covered for?”
- “Does it require a prior authorization?”
- “Does my plan exclude medications used to treat obesity?”
That last question is important.
If obesity medications are a plan exclusion, the issue may not be whether you medically qualify for treatment. Your insurance plan may simply have decided not to include that benefit.
You can also ask what your estimated copay or coinsurance will be.
Because “covered” and “cheap” are unfortunately not synonyms.
What If My GLP-1 Is Denied?
A denial does not always mean the conversation is over.
The first step is figuring out why it was denied.
Maybe your insurance needs more information. Maybe a prior authorization is required. Maybe you have to meet certain criteria before they will approve the medication.
In those cases, your healthcare provider may be able to submit additional information or appeal the decision when appropriate.
But sometimes the medication is simply excluded from your insurance plan.
That is different.
If your plan does not include coverage for obesity medications, sending more paperwork usually won’t change the answer.
A denial may have a next step. A plan exclusion may not.
Either way, knowing why your medication wasn’t covered can help you and your healthcare provider figure out what options make sense from there.
GLP-1 Treatment at Storm Wellness Northwest
At Storm Wellness Northwest in Vancouver, Washington, we treat obesity as a medical condition—not a character flaw and definitely not a simple math problem involving calories.
We look at the bigger picture.
This includes reviewing your medical history, metabolic health, body composition, nutrition, muscle, hormones, medications, sleep, and the other pieces that affect long-term health.
For some patients, GLP-1 medication may be part of that plan.
For others, it may not be.
And if insurance is involved, we can help you understand what information may be needed for appropriate medical treatment and insurance authorization.
Because healthcare is complicated enough.
Looking for GLP-1 Treatment in Vancouver, WA or the Portland Area?
If you live in Vancouver, Salmon Creek, Ridgefield, Battle Ground, Camas, Portland, or the surrounding Southwest Washington and Portland metro area,Storm Wellness Northwest can help you explore your options for medically guided weight management and better metabolic health.
Insurance coverage is only one part of the conversation.
The more important question is:
“What treatment makes sense for you?”
And that is a much better place to start.